Here at Regen IV Wellness, we are committed to doing our part in helping our clients and our community in battling COVID-19 and its debilitating symptoms. One of the ways that we have seen significant improvement in our client’s that have been diagnosed with COVID-19 is the Regeneron Monoclonal Antibody Infusion. Learn more about it by reading some of the most frequently asked questions that we have received regarding this treatment.
How does Regeneron Monoclonal Antibody Infusion work?
The moment a person becomes infected with COVID-19, our bodies begin to produce antibodies to fight back the infection. Unfortunately, your body’s response and production of these antibodies takes time to produce enough to beat back the infection.
Regeneron’s antibody treatment helps your body at the very beginning to produce a great number of antibodies that will reduce symptoms and lower the risk of hospitalization and death by an average of 70 percent. A Regeneron study also showed 72 percent protection against symptomatic infection in the first week, and 93 percent protection in subsequent weeks. Among the people who did have symptoms, those on the treatment cleared the virus faster and had a shorter time being sick.
Can most patients tolerate antibody treatment?
Monoclonal antibodies are already used to fight many cancers and autoimmune diseases and are generally well-tolerated by patients. Most doctors believe that Regeneron’s cocktail and its impact on clients is similar to other antibody treatments that have been used for many years.
This treatment is recommended for non-hospitalized adults and pediatric patients 12 years of age and older that have tested positive for COVID-19, are at high-risk of developing a severe form of the disease and are within 10 days of developing symptoms. While this breakthrough in COVID-19 treatment is great for many patients, it is not recommended for those who are already hospitalized or are requiring oxygen.
Has the FDA weighed-in on Regeneron?
In November 2020, the FDA granted emergency use authorization for providers to use the antibody treatment for their clients. In August 2021, the FDA expanded Regeneron’s Monoclonal Antibody Infusion to include post-exposure prophylaxis. This means those that have been exposed to COVID-19 and are at high-risk of becoming positive and developing severe symptoms can now receive this treatment as a means of prevention.
Is Regeneron’s Antibody Infusion a substitute for the vaccine?
While Regeneron’s Antibody Infusion is a great medical breakthrough for counteracting COVID-19 symptoms, the FDA does not advise people to use this treatment as a vaccine substitute. The agency still urges everyone who is eligible to get vaccinated.
Get on the road to recovery quickly by scheduling an appointment for your monoclonal antibody infusion today. Don't qualify for the monoclonal antibody infusion, or it's not a right fit? Regen IV Wellness offers a variety of COVID-19 therapies to fit your needs. Call us to find out the variety of therapies, treatments, and preventive care we offer at our facility at 214.326.0033.
*These statements have not been evaluated or approved by the Food and Drug Administration. Our therapies are not intended to diagnose, treat, cure or prevent any disease.
Signup for news and special offers!
You have successfully joined our subscriber list.